EUVIMEDEUVIMED entdecken
Crossref

Platelet MicroRNA-484 as a Novel Diagnostic Biomarker for Acute Coronary Syndrome

Parisa Masoodi Khabar, Mohamad Esmail Ghydari, Nader Vazifeh Shiran, Mohammadreza Shirazy, Mohsen Hamidpour

Laboratory Medicine · 2023

DOI: 10.1093/labmed/lmac102 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Laboratory Medicine, 2023. Verfasst von Parisa Masoodi Khabar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Blood Banking, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Acute Coronary Syndrome, MicroRNAs, Coronary Artery Disease. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Shahid Beheshti University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Platelet microRNAs (miRs) have been indicated as a diagnostic biomarker in various diseases, including acute coronary syndrome (ACS). This study aimed to investigate the expression of miR-223-5p, miR-126-5p, miR-484, and miR-130a-3p in individuals with coronary artery disease (CAD).

Methods

Forty subjects with CAD and 13 healthy individuals were under study. The expression of miR-223-5p, miR-126-5p, miR-484, and miR-130a-3p was measured in platelets by quantitative reverse transcription–polymerase chain reaction. The relationship between miRNA expression and various parameters of the subjects was analyzed using analysis of variance and Spearman and t-tests.

Results

The miR-484 expression was significantly upregulated in the ACS subjects (P = .0097). Moreover, miR-484 had diagnostic value for screening subjects with unstable angina vs controls (area under the curve [AUC] = 0.978, 95% confidence interval [CI] 0.92–1, P = .0006) and NSTEMI patients versus controls (AUC = 0.910, 95% CI 0.74–1, P = .005).

Conclusion

The results of this study indicate that the upregulated expression of miR-484 in ACS patients might be used as a diagnostic biomarker in ACS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Coronary SyndromeMicroRNAsCoronary Artery DiseaseHumansBlood PlateletsBiomarkers

Stichwörter der Autor:innen

126130a2233p4845pacute coronary syndromemiRplatelet

Substanzen

MicroRNAsBiomarkersMIRN484 microRNA, human

Autor:innen und Institutionen

  • Department of Hematology and Blood Banking, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Department of Cardiology, Taleghani General Hospital, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Hematopoietic Stem Cell Research Centre - Department of Hematology and Blood Banking, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Förderung

  • Shahid Beheshti University of Medical Sciences

Zitieren

APA

Masoodi Khabar, P., Ghydari, M. E., Vazifeh Shiran, N., Shirazy, M., & Hamidpour, M. (2023). Platelet MicroRNA-484 as a Novel Diagnostic Biomarker for Acute Coronary Syndrome. Laboratory Medicine. https://doi.org/10.1093/labmed/lmac102

Vancouver

Masoodi Khabar P, Ghydari ME, Vazifeh Shiran N, Shirazy M, Hamidpour M. Platelet MicroRNA-484 as a Novel Diagnostic Biomarker for Acute Coronary Syndrome. Laboratory Medicine. 2023. doi:10.1093/labmed/lmac102

BibTeX
@article{MasoodiKhabar2023,
  author = {Masoodi Khabar, Parisa and Ghydari, Mohamad Esmail and Vazifeh Shiran, Nader and Shirazy, Mohammadreza and Hamidpour, Mohsen},
  title = {Platelet MicroRNA-484 as a Novel Diagnostic Biomarker for Acute Coronary Syndrome},
  journal = {Laboratory Medicine},
  year = {2023},
  doi = {10.1093/labmed/lmac102}
}
Kostenlos starten →